Global Intravenous Immunoglobulin Market Analysis & Trends - Industry Forecast to 2025

  • ID: 3788853
  • Report
  • Region: Global
  • 195 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Baxter International Inc
  • BDI Pharma Inc
  • Biotest AG
  • Biotest AG
  • CSL Limited
  • Grifols, S.A
  • MORE
The Intravenous Immunoglobulin market is poised to grow strong during the forecast period 2017 to 2025. Some of the prominent trends that the market is witnessing include improving health care infrastructure across the globe, increasing number of chronic inflammatory demyelinating polyneuropathy (CIDP) patients and technological developments in the methods used for production and purification of IVIG products.

Based on therapeutic area the market is categorized into acute infections, immune deficiencies and autoimmune diseases. Furthermore Immune Deficiencies are divided into x-linked agammaglobulinemia, acquired compromised immunity conditions and hypogammaglobulinemia (primary immune deficiencies). Autoimmune Diseases are segmented into inflammatory diseases and immune thrombocytopenia (ITP).

Depending on product types the market is segregated by IGM, IGG, IGE, Immunoglobulin D (IGD) and IGA.

On the basis of plasma protein the market is bifurcated into albumin, factor IX, polyvalent IVIG, hyperimmunes (IM&IV) and factor VIII.

In terms of end user the market is segmented into home care, hospitals and clinics.

By application the market is classified into primary humoral immunodeficiency, immunodeficiency diseases, myasthenia gravis, hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), inflammatory myopathies, kawasaki disease, idiopathic thrombocytopenic purpura (ITP), guillain-barre syndrome (GBS), chronic lymphocytic leukemia, specific antibody deficiency (SAD), multifocal motor neuropathy, congenital AIDS and other applications.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
  • US
  • Canada
  • Mexico
Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
Middle East
  • Saudi Arabia
  • UAE
  • Rest of Middle East
Latin America
  • Argentina
  • Brazil
  • Rest of Latin America
Rest of the World
  • South Africa
  • Others
Report Highlights:
  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2025, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2025
  • Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Baxter International Inc
  • BDI Pharma Inc
  • Biotest AG
  • Biotest AG
  • CSL Limited
  • Grifols, S.A
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 End User Analysis
1.6 Application Analysis
1.7 Strategic Benchmarking
1.8 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Improving Health Care Infrastructure across the Globe
3.1.2 Increasing Number of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients
3.1.3 Technological Developments in the Methods used for Production and Purification of IVIG Products
3.1.4 Growth Opportunities/Investment Opportunities

4 Global Intravenous Immunoglobulin Market, By Therapeutic Area
4.1 Acute Infections
4.1.1. Acute Infections Market Forecast to 2025 (US$ MN)
4.2 Immune Deficiencies
4.2.1 Immune Deficiencies Market Forecast to 2025 (US$ MN)
4.2.1.1 X-linked Agammaglobulinemia
4.2.1.1.1 X-linked Agammaglobulinemia Market Forecast to 2025 (US$ MN)
4.2.1.2 Acquired Compromised Immunity Conditions
4.2.1.2.1 Acquired Compromised Immunity Conditions Market Forecast to 2025 (US$ MN)
4.2.1.3 Hypogammaglobulinemia (Primary Immune Deficiencies)
4.2.1.3.1 Hypogammaglobulinemia (Primary Immune Deficiencies) Market Forecast to 2025 (US$ MN)
4.3 Autoimmune Diseases
4.3.1 Autoimmune Diseases Market Forecast to 2025 (US$ MN)
4.3.1.1 Inflammatory Diseases
4.3.1.1.1 Inflammatory Diseases Market Forecast to 2025 (US$ MN)
4.3.1.2 Immune Thrombocytopenia (ITP)
4.3.1.2.1 Immune Thrombocytopenia (ITP) Market Forecast to 2025 (US$ MN)

5 Global Intravenous Immunoglobulin Market, By Product Type
5.1 IGM
5.1.1 IGM Market Forecast to 2025 (US$ MN)
5.2 IGG
5.2.1 IGG Market Forecast to 2025 (US$ MN)
5.3 IGE
5.3.1 IGE Market Forecast to 2025 (US$ MN)
5.4 Immunoglobulin D (IGD)
5.4.1 Immunoglobulin D (IGD) Market Forecast to 2025 (US$ MN)
5.5. IGA
5.5.1 IGA Market Forecast to 2025 (US$ MN)

6 Global Intravenous Immunoglobulin Market, By Plasma Protein
6.1 Albumin
6.1.1 Albumin Market Forecast to 2025 (US$ MN)
6.2 Factor IX
6.2.1 Factor IX Market Forecast to 2025 (US$ MN)
6.3 Polyvalent IVIG
6.3.1 Polyvalent IVIG Market Forecast to 2025 (US$ MN)
6.4 Hyperimmunes (IM&IV)
6.4.1 Hyperimmunes (IM&IV) Market Forecast to 2025 (US$ MN)
6.5 Factor VIII
6.5.1. Factor VIII Market Forecast to 2025 (US$ MN)

7 Global Intravenous Immunoglobulin Market, By End User
7.1 Home Care
7.1.1 Home Care Market Forecast to 2025 (US$ MN)
7.2 Hospitals
7.2.1 Hospitals Market Forecast to 2025 (US$ MN)
7.3 Clinics
7.3.1 Clinics Market Forecast to 2025 (US$ MN)

8 Global Intravenous Immunoglobulin Market, By Application
8.1 Primary Humoral Immunodeficiency
8.1.1 Primary Humoral Immunodeficiency Market Forecast to 2025 (US$ MN)
8.2 Immunodeficiency Diseases
8.2.1 Immunodeficiency Diseases Market Forecast to 2025 (US$ MN)
8.3 Myasthenia Gravis
8.3.1 Myasthenia Gravis Market Forecast to 2025 (US$ MN)
8.4 Hypogammaglobulinemia
8.4.1 Hypogammaglobulinemia Market Forecast to 2025 (US$ MN)
8.5 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
8.5.1 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Forecast to 2025 (US$ MN)
8.6 Inflammatory Myopathies
8.6.1 InflammatoryY Myopathies Market Forecast to 2025 (US$ MN)
8.7 Kawasaki Disease
8.7.1 Kawasaki Disease Market Forecast to 2025 (US$ MN)
8.8 Idiopathic Thrombocytopenic Purpura (ITP)
8.8.1 Idiopathic Thrombocytopenic Purpura (ITP) Market Forecast to 2025 (US$ MN)
8.9 Guillain-Barre Syndrome (GBS)
8.9.1 Guillain-Barre Syndrome (GBS) Market Forecast to 2025 (US$ MN)
8.10 Chronic Lymphocytic Leukemia
8.10.1 Chronic Lymphocytic Leukemia Market Forecast to 2025 (US$ MN)
8.11 Specific Antibody Deficiency (SAD)
8.11.1 Specific Antibody Deficiency (SAD) Market Forecast to 2025 (US$ MN)
8.12 Multifocal Motor Neuropathy
8.12.1 Multifocal Motor Neuropathy Market Forecast to 2025 (US$ MN)
8.13 Congenital AIDS
8.13.1 Congenital AIDS Market Forecast to 2025 (US$ MN)
8.14 Other Applications
8.14.1 Other Applications Market Forecast to 2025 (US$ MN)

9 Global Intravenous Immunoglobulin Market, By Geography
9.1 North America
9.1.1 North America Market Forecast By Countries to 2025 (US$ MN)
9.1.1.1 US
9.1.1.2 Canada
9.1.1.3 Mexico
9.2 Europe
9.2.1 Europe Market Forecast By Countries to 2025 (US$ MN)
9.2.1.1 Germany
9.2.1.2 U.K.
9.2.1.3 Italy
9.2.1.4 France
9.2.1.5 Spain
9.2.1.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Asia Pacific Market Forecast By Countries to 2025 (US$ MN)
9.3.1.1 Japan
9.3.1.2 China
9.3.1.3 India
9.3.1.4 Australia
9.3.1.5 New Zealand
9.3.1.6 Rest of APAC
9.4 Middle East
9.4.1 Middle East Market Forecast By Countries to 2025 (US$ MN)
9.4.1.1 Saudi Arabia
9.4.1.2 UAE
9.4.1.3 Rest of Middle East
9.5 Latin America
9.5.1 Latin America Market Forecast By Countries to 2025 (US$ MN)
9.5.1.1 Argentina
9.5.1.2 Brazil
9.5.1.3 Rest of Latin America
9.6 Rest of the World (RoW)
9.6.1 RoW Market Forecast By Countries to 2025 (US$ MN)
9.6.1.1 South Africa
9.6.1.2 Others

10 Key Player Activities
10.1 Mergers & Acquisitions
10.2 Partnerships, Joint Venture’s, Collaborations and Agreements
10.3 Product Launch & Expansions
10.4 Other Activities

11 Leading Companies
11.1 Biotest AG
11.2 Guizhou Taibang Biological Products Co.
11.3 Baxter International Inc
11.4 China Biologic Products, Inc
11.5 Shanghai RAAS Blood Products Co., Ltd
11.6 Grifols, S.A
11.7 Beijing Tiantan Biological Products Co., Ltd
11.8 Octapharma AG
11.9 CSL Limited
11.10 Hualan Biological Engineering Inc
11.11 Kedrion Biopharma
11.12 Biotest AG
11.13 OMRIX Biopharmaceuticals Ltd
11.14 LFB BIOTECHNOLOGIES
11.15 BDI Pharma Inc

List of Tables
Table 1 Global Intravenous Immunoglobulin Market By Region, Market forecast (2014-2025) (US $MN)
Table 2 Global Intravenous Immunoglobulin Market By Therapeutic Area, Market forecast (2014-2025) (US $MN)
Table 3 Global Intravenous Immunoglobulin Market By Acute Infections, Market forecast (2014-2025) (US $MN)
Table 4 Global Intravenous Immunoglobulin Market By Immune Deficiencies, Market forecast (2014-2025) (US $MN)
Table 5 Global Intravenous Immunoglobulin Market By X-linked Agammaglobulinemia, Market forecast (2014-2025) (US $MN)
Table 6 Global Intravenous Immunoglobulin Market By Acquired Compromised Immunity Conditions, Market forecast (2014-2025) (US $MN)
Table 7 Global Intravenous Immunoglobulin Market By Hypogammaglobulinemia (Primary Immune Deficiencies), Market forecast (2014-2025) (US $MN)
Table 8 Global Intravenous Immunoglobulin Market By Autoimmune Diseases, Market forecast (2014-2025) (US $MN)
Table 9 Global Intravenous Immunoglobulin Market By Inflammatory Diseases, Market forecast (2014-2025) (US $MN)
Table 10 Global Intravenous Immunoglobulin Market By Immune Thrombocytopenia (ITP), Market forecast (2014-2025) (US $MN)
Table 11 Global Intravenous Immunoglobulin Market By Product Types, Market forecast (2014-2025) (US $MN)
Table 12 Global Intravenous Immunoglobulin Market By IGM, Market forecast (2014-2025) (US $MN)
Table 13 Global Intravenous Immunoglobulin Market By IGG, Market forecast (2014-2025) (US $MN)
Table 14 Global Intravenous Immunoglobulin Market By IGE, Market forecast (2014-2025) (US $MN)
Table 15 Global Intravenous Immunoglobulin Market By Immunoglobulin D (IGD), Market forecast (2014-2025) (US $MN)
Table 16 Global Intravenous Immunoglobulin Market By IGA, Market forecast (2014-2025) (US $MN)
Table 17 Global Intravenous Immunoglobulin Market By Plasma Protein, Market forecast (2014-2025) (US $MN)
Table 18 Global Intravenous Immunoglobulin Market By Albumin, Market forecast (2014-2025) (US $MN)
Table 19 Global Intravenous Immunoglobulin Market By Factor IX, Market forecast (2014-2025) (US $MN)
Table 20 Global Intravenous Immunoglobulin Market By Polyvalent IVIG, Market forecast (2014-2025) (US $MN)
Table 21 Global Intravenous Immunoglobulin Market By Hyperimmunes (IM&IV), Market forecast (2014-2025) (US $MN)
Table 22 Global Intravenous Immunoglobulin Market By Factor VIII, Market forecast (2014-2025) (US $MN)
Table 23 Global Intravenous Immunoglobulin Market By End User, Market forecast (2014-2025) (US $MN)
Table 24 Global Intravenous Immunoglobulin Market By Home Care, Market forecast (2014-2025) (US $MN)
Table 25 Global Intravenous Immunoglobulin Market By Hospitals, Market forecast (2014-2025) (US $MN)
Table 26 Global Intravenous Immunoglobulin Market By Clinics, Market forecast (2014-2025) (US $MN)
Table 27 Global Intravenous Immunoglobulin Market By Application, Market forecast (2014-2025) (US $MN)
Table 28 Global Intravenous Immunoglobulin Market By Primary Humoral Immunodeficiency, Market forecast (2014-2025) (US $MN)
Table 29 Global Intravenous Immunoglobulin Market By Immunodeficiency Diseases, Market forecast (2014-2025) (US $MN)
Table 30 Global Intravenous Immunoglobulin Market By Myasthenia Gravis, Market forecast (2014-2025) (US $MN)
Table 31 Global Intravenous Immunoglobulin Market By Hypogammaglobulinemia, Market forecast (2014-2025) (US $MN)
Table 32 Global Intravenous Immunoglobulin Market By Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Market forecast (2014-2025) (US $MN)
Table 33 Global Intravenous Immunoglobulin Market By Inflammatory Myopathies, Market forecast (2014-2025) (US $MN)
Table 34 Global Intravenous Immunoglobulin Market By Kawasaki Disease, Market forecast (2014-2025) (US $MN)
Table 35 Global Intravenous Immunoglobulin Market By Idiopathic Thrombocytopenic Purpura (ITP), Market forecast (2014-2025) (US $MN)
Table 36 Global Intravenous Immunoglobulin Market By Guillain-Barre Syndrome (GBS), Market forecast (2014-2025) (US $MN)
Table 37 Global Intravenous Immunoglobulin Market By Chronic Lymphocytic Leukemia, Market forecast (2014-2025) (US $MN)
Table 38 Global Intravenous Immunoglobulin Market By Specific Antibody Deficiency (SAD), Market forecast (2014-2025) (US $MN)
Table 39 Global Intravenous Immunoglobulin Market By Multifocal Motor Neuropathy, Market forecast (2014-2025) (US $MN)
Table 40 Global Intravenous Immunoglobulin Market By Congenital AIDS, Market forecast (2014-2025) (US $MN)
Table 41 Global Intravenous Immunoglobulin Market By Other Applications, Market forecast (2014-2025) (US $MN)

NOTE: Regional tables for North America, Europe, Asia Pacific, Middle East, Latin America and RoW are presented in similar manner as the above
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Biotest AG
  • Guizhou Taibang Biological Products Co.
  • Baxter International Inc
  • China Biologic Products, Inc
  • Shanghai RAAS Blood Products Co., Ltd
  • Grifols, S.A
  • Beijing Tiantan Biological Products Co., Ltd
  • Octapharma AG
  • CSL Limited
  • Hualan Biological Engineering Inc
  • Kedrion Biopharma
  • Biotest AG
  • OMRIX Biopharmaceuticals Ltd
  • LFB BIOTECHNOLOGIES
  • BDI Pharma Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll